Please assess the completion status of the following clinical trial:

Trial Title: Cathodal tDCS in MCI: A Randomized, Double-Blind, Sham-Controlled Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients with confirmed MCI diagnosis~* Age 55-85~* Right handed (tested using the Edinburgh handedness inventory)~* Total PHQ-8 of ≤ 16 which signifies no severe depression~* All participants and/or caregivers must be able to provide informed consent~Exclusion Criteria:~* Neurodegenerative disease (e.g. Parkinson's, Huntington's, Multiple Sclerosis) other than MCI~* Previous brain lesion~* Intracranial abnormality such as prior stroke~* History of seizure disorder or epilepsy~* A true positive response, after patient clarification, to any question on the modified TMS/tDCS Adult Safety Screen questionnaire that would impact patient safety~* Any history of brain stimulation treatment (e.g., electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), vagal nerve therapy (VNS), deep brain stimulation (DBS))~* Use of any investigational drug within 4 weeks~* Cardiac pacemakers, implanted medication pumps, intracardiac lines; acute or unstable cardiac disease; intracranial implants (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or any other metal object within or near the head (exception: mouth/dental work) that cannot be safely removed~* Known or suspected pregnancy (extremely unlikely as the age range for this study is 55-85 years)

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Active tDCS (Type: ACTIVE_COMPARATOR): Active tDCS uses the Soterix Medical 1x1 Low Intensity Transcranial Electrical Stimulator (tES) Model 2001. The active tDCS intervention include stimulation for 15 minutes at 1mA. The cathode electrode will be placed over the right dorsolateral prefrontal cortex with reference electrode (anode) over the left dorsolateral prefrontal cortex. Both electrodes are covered by saline-soaked sponges that are held against the scalp by a pair of large, adjustable head straps. Treatment sessions will last for 15 minutes. 5 consecutive treatment sessions will be completed within 1 week.
- Sham tDCS (Type: SHAM_COMPARATOR): Sham tDCS uses the Soterix Medical 1x1 Low Intensity Transcranial Electrical Stimulator (tES) Model 2001. The sham tDCS intervention lasts for 15 minutes. The cathode electrode will be placed over the right dorsolateral prefrontal cortex with reference electrode (anode) over the left dorsolateral prefrontal cortex. Both electrodes are covered by saline-soaked sponges that are held against the scalp by a pair of large, adjustable head straps. Treatment sessions will last for 15 minutes. 5 consecutive treatment sessions will be completed within 1 week.

Based on this trial design, predict the completion outcome and termination type (if applicable).